Figure 1 (A) T₁ weighted axial MR scan of a 43 year old male patient after contrast application shows meningeal inflammatory involvement with 3 mm thickening of the left hemispherical and right frontal meninges (arrows). (B) Six months after treatment with infliximab (5 mg/kg body wt) at weeks 0, 2, 6 and 8‐weekly thereafter, meningeal contrast enhancement and thickening had clearly regressed.